SciELO - Scientific Electronic Library Online

 
vol.41 número3Cumplimiento de indicadores de calidad de atención en pacientes con Lupus Eritematoso sistémico en el Hospital de ClínicasToma de decisiones en cáncer de próstata: un análisis de la influencia y significado de los comités de tumores en una cohorte de pacientes tratados con radioterapia o prostatectomía índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Revista Médica del Uruguay

versión impresa ISSN 0303-3295versión On-line ISSN 1688-0390

Resumen

QUIROZ, Luca et al. Study of drug interactions in hospitalized patients at a university hospital. Rev. Méd. Urug. [online]. 2025, vol.41, n.3, e206.  Epub 16-Jun-2025. ISSN 0303-3295.  https://doi.org/10.29193/rmu.41.3.6.

Introduction:

adverse drug reactions are a major cause of morbidity and mortality in patients. Understanding drug interactions that may trigger these events is essential for prevention.

Objectives:

to describe drug–drug interactions in a cohort of patients admitted to a medical ward in a university hospital.

Materials and methods:

descriptive, cross-sectional study. Patient prescriptions and drug interactions were assessed over a 2-month period using the Micromedex® software. Major interactions and contraindications were analyzed. Associations were examined with age, sex, number of drugs prescribed, and length of hospital stay.

Results:

a total of 57 patients were included. In 24 patients (42%), 109 major interactions and 8 contraindications were detected. Patients with interactions had longer hospital stays (26.5 vs 13.8 days, p=0.003) and received more medications per day (9 vs 7.5, p=0.061). No differences were found in age or sex. The most frequently involved drugs were opioids, antipsychotics, antithrombotics, antidepressants, and benzodiazepines. Psychotropic drugs were involved in 58.1% of interactions. The most common potential adverse effects were central nervous system depression, QT interval prolongation, and bleeding risk.

Conclusions:

drug–drug interactions are a common issue among hospitalized patients. Building multidisciplinary teams, being aware of potential interactions, and actively monitoring for adverse effects are key to ensuring patient safety.

Palabras clave : Drug interactions; Patient safety; Drug-related adverse effects; Inpatient pharmacy.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )